Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia. van der Pluijm M, Wengler K, Reijers PN, Cassidy CM, et al. Am J Psychiatry 2024 Mar 13:appiajp20220780. doi: 10.1176/appi.ajp.20220780.

Read + Share

Amedeo Smart

Independent Medical Education

van der Pluijm M, Wengler K, Reijers PN, Cassidy CM, et al. Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia. Am J Psychiatry 2024 Mar 13:appiajp20220780. doi: 10.1176/appi.ajp.20220780.
PMID: 38476044